- Reuters reported that a two-week pilot strike in July over collective agreements and delayed aircraft deliveries contributed to the Scandinavian airline SAS AB’s (OTC:SASDY) decision to cancel 1,700 flights in the upcoming months.
- Related: SAS Airline Cancels Flight On Pilot Shortage, Though Passenger Volume Jumped
- According to SAS, 1,700 flights, or around 4% of all flights, had been canceled in September and October.
- “It is the effects from the strike but also delayed deliveries of aircraft and some other factors,” the report quoted a SAS spokesperson, adding that the company does not see lower demand.
- Related: Pilot Strike Forces SAS To File For Chapter 11 Bankruptcy In US
- Last week, SAS said it had agreed with American private equity company Apollo Global Management (NYSE:APO) to provide bridge funding during chapter 11 bankruptcy protection proceedings in the U.S.
- Photo Via Company
Pliant Therapeutics Earlier Announced Data From The Integris-IPF Phase 2a Trial Demonstrating Bexotegrast 320 Mg Was Well Tolerated And Achieved Statistically Significant FVC Increase In Patients With Idiopathic Pulmonary Fibrosis; Trial Met Primary An…
Pliant Therapeutics, Inc. (NASDAQ: PLRX) today announced 12-week interim data from the 320 mg dose group of INTEGRIS-IPF, a multinational, randomized, double-blind, placebo-controlled Phase 2a clinical trial of bexotegrast (PLN-74809) in patients with idiopathic pulmonary fibrosis (IPF).
